These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 32994589)

  • 61. COVID-19 diffusion capability is its worst, unpredictable chracateristic. How to visit a patient from a distance.
    Sterpetti AV
    Br J Surg; 2020 Jun; 107(7):e181. PubMed ID: 32329517
    [No Abstract]   [Full Text] [Related]  

  • 62. Coronavirus: origins, signs, prevention and management of patients.
    Hill B
    Br J Nurs; 2020 Apr; 29(7):399-402. PubMed ID: 32279552
    [No Abstract]   [Full Text] [Related]  

  • 63. COVID-19 and the Duty to Protect from Communicable Diseases.
    Ghossoub E; Newman WJ
    J Am Acad Psychiatry Law; 2020 Jun; 48(2):155-160. PubMed ID: 32385050
    [No Abstract]   [Full Text] [Related]  

  • 64. Nonpharmaceutical interventions for tackling the COVID-19 epidemic in Brazil.
    Garcia LP; Duarte E
    Epidemiol Serv Saude; 2020 Apr; 29(2):e2020222. PubMed ID: 32294756
    [No Abstract]   [Full Text] [Related]  

  • 65. COVID-19 in Greece: People take precedence over economics.
    Papadimos TJ
    J Glob Health; 2020 Dec; 10(2):020337. PubMed ID: 33110537
    [No Abstract]   [Full Text] [Related]  

  • 66. COVID-19 in Malaysia: Crucial measures in critical times.
    Ganasegeran K; Ch'ng ASH; Looi I
    J Glob Health; 2020 Dec; 10(2):020333. PubMed ID: 33110533
    [No Abstract]   [Full Text] [Related]  

  • 67. Rethinking dermatology resident education in the age of COVID-19.
    Ko LN; Chen ST; Huang JT; McGee JS; Liu KJ
    Int J Dermatol; 2020 Dec; 59(12):1539-1540. PubMed ID: 33026650
    [No Abstract]   [Full Text] [Related]  

  • 68. Social Determinants of Health Are Needed in COVID-19 Risk Assessments for the Workforce.
    Kalia N; Conard S; Kusti M; Yuspeh L; Leung N; Tao XG; Kuy S; Alfriend AS; Bernacki EJ
    J Occup Environ Med; 2020 Nov; 62(11):e673-e676. PubMed ID: 32941348
    [No Abstract]   [Full Text] [Related]  

  • 69. Labor and Delivery Visitor Policies During the COVID-19 Pandemic: Balancing Risks and Benefits.
    Arora KS; Mauch JT; Gibson KS
    JAMA; 2020 Jun; 323(24):2468-2469. PubMed ID: 32442264
    [No Abstract]   [Full Text] [Related]  

  • 70. Vets can help government tackle Covid-19.
    Waters A
    Vet Rec; 2020 Apr; 186(14):429. PubMed ID: 32299959
    [No Abstract]   [Full Text] [Related]  

  • 71. Lockdown poses new challenges for cancer care in India.
    Sharma DC
    Lancet Oncol; 2020 Jul; 21(7):884. PubMed ID: 32479789
    [No Abstract]   [Full Text] [Related]  

  • 72. Amesh Adalja: taking pandemic preparation seriously.
    Bull World Health Organ; 2020 May; 98(5):304-305. PubMed ID: 32514195
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Recommendations on contingency operations for hospitals in response to COVID-19 cases identified in inpatients - Taiwan.
    Chien LJ; Su CH; Wu HH
    J Formos Med Assoc; 2020 Nov; 119(11):1572-1574. PubMed ID: 32475730
    [No Abstract]   [Full Text] [Related]  

  • 74. Reorganize and survive-a recommendation for healthcare services affected by COVID-19-the ophthalmology experience.
    Petrovski BÉ; Lumi X; Znaor L; Ivastinović D; Confalonieri F; Petrovič MG; Petrovski G
    Eye (Lond); 2020 Jul; 34(7):1177-1179. PubMed ID: 32313170
    [No Abstract]   [Full Text] [Related]  

  • 75. Covid-19: social distancing or social isolation?
    Gupta R; Dhamija RK
    BMJ; 2020 Jun; 369():m2399. PubMed ID: 32554394
    [No Abstract]   [Full Text] [Related]  

  • 76. Medical considerations for supporting elite athletes during the post-peak phase of the New Zealand COVID-19 pandemic: a New Zealand sporting code consensus.
    Hamilton B; Anderson L; Anglem N; Armstrong S; Baker S; Beable S; Burt P; Coleman L; Doughty R; Edwards T; Exeter D; Fulcher M; Kara S; Mayhew J; Mayhew S; Milne C; O'Neill B; Osborne H; Parnell M; Pearson J; Rasmussen K; Scheffer J; Swan M; Thomas M; Gerrard D
    N Z Med J; 2020 Jun; 133(1517):107-116. PubMed ID: 32595225
    [No Abstract]   [Full Text] [Related]  

  • 77. Quantifying what could have been - The impact of the Australian and New Zealand governments' response to COVID-19.
    Varghese C; Xu W
    Infect Dis Health; 2020 Nov; 25(4):242-244. PubMed ID: 32507662
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Associations between restrictions on public mobility and slowing of new COVID-19 case rates in three countries.
    Tran TH; Sasikumar SN; Hennessy A; O'Loughlin A; Morgan L
    Med J Aust; 2020 Nov; 213(10):471-473. PubMed ID: 33043444
    [No Abstract]   [Full Text] [Related]  

  • 79. Spread of SARS-CoV-2.
    Stower H
    Nat Med; 2020 Apr; 26(4):465. PubMed ID: 32273606
    [No Abstract]   [Full Text] [Related]  

  • 80. The impact of COVID-19 control measures on the morbidity of varicella, herpes zoster, rubella and measles in Guangzhou, China.
    Wu D; Liu Q; Wu T; Wang D; Lu J
    Immun Inflamm Dis; 2020 Dec; 8(4):844-846. PubMed ID: 33026189
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.